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Crystals of the complex of bovine a-thrombin with
recombinant hirudin variant 1 have space group C22Z1
with cel! constants a = 59.11, b = 102.62, and c =
143.26 A. The orientation and position of the thrombin
component was determined by molecular replacement
and the hirudin molecule was fit in
21F0J lFel electron
density maps. The structure was refinedby restrained
least-squares and simulated annealing to R = 0.161 at
2.8-A resolution. The binding of hirudin to thrombin
is generally similar to that observed in the crystals of
human thrombin-hirudin. Several differences in the
interactions of the COOH-terminal polypeptide of hirudin, specifically of residues Asp-55h, Phe-56h, Glu57h, and Glu-58h, and a few differences in the interactions of the hirudin core, specificallyof residues AspSh, Ser-19h,and Asn-ZOh, with thrombin from human
thrombin-hirudin suggest that there is some flexibility
in the binding of these 2 molecules. Most of the residues
in the 9 subsites that bind fibrinopeptide A,-,, to
thrombin also interact with the NH2-terminal domain
of hirudin. The S1 subsite is a notable exception in that
only 1 of its 6 residues, namely Ser-214, interacts with
hirudin. The only difference between human and bovine thrombins that appears to influence the binding
of hirudin is the replacement of Lys-149E by anacidic
glutamate in the bovine enzyme.

1991, and references therein). Free thrombinaccelerates clotting by activating platelets and key enzymes in the clotting
cascade, such as factor V, factor VIII, factor XI, and factor
XIII, whereas thrombin bound to thrombomodulin attenuates
clotting by activating proteinC, which then inactivates factors
Va and VIIIa (Esmon, 1987; Dittman and Majerus, 1990).
a-Thrombin consists of two polypeptide chains, A and B,
a-thrombin
connected througha single disulfide bond. Bovine
has 49 amino acid residues in the A-chain and 259 residues
in the B-chain (Magnusson et al., 1975; MacGillivray and
Davie, 1984; Walz et al., 1986) whereas human a-thrombin
has 36 residues, afterthe loss of a tridecapeptideduring
activation from prothrombin, in the A-chain,of which 27 are
identical with those in bovine thrombin, and 259 in the Bchain, of which 225 areidentical(Butkowski et al., 1977;
Degan et al., 1983; Walz et al., 1986). The B-chain containsa
carbohydrate at Asn-6OG and the active site residues His-57,
Asp-108, and Ser-195.’
The most potent natural inhibitor of thrombin known is
hirudin, which is a small protein containing 65 residues and
3 disulfide bonds that is
isolated from the glandular secretions
of the leech Hirudo medicinalis (Markwardt, 1970). The dissociation constants for the noncovalent, equimolar complex
of hirudin withbovine thrombin or with human thrombin are
3.0 p~ and 0.3 PM, respectively (Dodt et al., 1988, 1990).
Hirudin blocks or greatly attenuates thrombin activity toward
fibrinogen, platelets, clotting factors, thrombomodulin, and
monocytes. Becausehirudin reactsonly with thrombin,is well
a-Thrombin (EC 3.4.21.5) is a serine protease with a high tolerated by the immune system, and has hemorrhagic
no
side
specificity for arginine bonds that playsa central role in effects, it is a potentially valuable drug for thromboembolic
thrombosis and hemostasis. It is the productof prothrombin disorders (Markwardt, 1991). The three-dimensional struccleavage by factor Xa in the final step of the blood clotting tures of the amino-terminal domain of two recombinant hicascade (reviewed by Mann, 1987; Davie et al., 1991). During rudins have been determined in solution by NMR methods
clotting, a-thrombin converts
fibrinogen into fibrinby remov- (Clore et al., 1987; Folkers et al., 1989; Haruyama and Wuthing fibrinopeptide A from the Aa-chain and fibrinopeptideB rich, 1989). In both cases, residues l h , 31h-36h, and 49h-65h
from theBP-chains of fibrinogen. Thrombin also functions as had no defined structure in solution.
a major regulator of hemostasis (Fenton, 1986; Davie et al.,
The crystal structures
of the complexes of human a-thrombin with recombinant hirudin variants1 (Griitter et al., 1990)
* This work was supported in partby National Institutes of Health
Grant GM 33192, the Wayne State University Center for Molecular and 2 (Rydelet al., 1990,1991) have been recentlydetermined.
Biology and Bristol-Myers Squibb Company (to B. F. P. E.), and by These studies reveal a mode of binding that has not been
SRI Internal Research and Development Projects 870D32XJC and previously observed for a protease inhibitor. The uniquefea391D32BKA and by funds provided by the Cigarette and Tobacco tures areas follows.
Surtax Fund of the State of California through the Tobacco-related
1) The contact area between hirudin and thrombin in the

-

Disease Research Program of the University of California (to P. H.
cJ.). Prior to publication, coordinates and structure factors willbe
deposited in the Brookhaven Protein Data Bank for release in May,
1993. In the interim, requests for the coordinates should be directed
t o B. E. The costs of publication of this article were defrayed in part
by the payment of page charges. This article must thereforebe hereby
marked “aduertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
§ T o whom correspondence and reprint requestsshould be addressed. Tel.: 313-577-5107.

The residue numbers for thrombin in this paper are assigned by
homology with chymotrypsin (Bode et al., 1989). A suffix denotes an
insertion in the thrombin sequence relative to that of chymotrypsin.
Sequence numbers for hirudin and fibrinopeptide residues are identified by the suffix “h” or “f,” respectively. The prime symbol (’)
denotes a residue number in a symmetry-related molecule. “Sn” is
used for the enzyme subsite that binds the nthresidue on the aminoterminal side of the scissile bond (Schechter and Berger, 1967).
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give 7688 uniquereflections.
complex is large, which probablyaccounts for the high affinity package(Howardetal.,1987)to
overall, unweighted, absolute R.,,was 0.099.QThefraction of oband selectivity of hirudin for thrombin. 2) The first3 residues The
served reflections for the shells m-7.0 A, 7.0-3.3 A, 3.3-3.0 A, 3.0-2.8
of hirudin bindat the active site of thrombin, but the primary A, and 2.8-2.6 A was 92%, 84%, 50%, 24%, and 13%, respectively.
specificity site of thrombin is notoccupied by hirudin. 3) The
Structure Solution-The orientation and position of the thrombin
last 16 residues of hirudin are in a n extended conformation component in the crystal was determined by the molecular replaceand bind at an anion binding
exosite on the surfaceof throm- ment method using the package MERLOT (Fitzgerald, 1988), molebin that extends from the
active site and is probably the cule 2 of bovine a-thrombin in the complex with fibrinopeptide A7.d~
(Martin et al.,1992) as theprobe, and 4u data between 7.0 and 3.5 A.
secondary fibrinogen binding site.
The rotational searchwas carried out with the fast rotation function
We undertook the structural analysis of the complex beof Crowther (1972) using the program CROSUM,
a radius of integratween bovine a-thrombin and recombinant hirudin variantl tion of 20.0 A, and grid interval of 2.5" in a , and 5.0" in @ and y.
for three reasons. The first was to gain more insight into the Three translation functions (Crowther and Blow, 1967) were cominteractions between hirudin and thrombin at the molecular puted with the program TRNSUM covering the entire unit cell and
with step size along a, b, and c of0.02 times the cell edge. The
level using a crystal form different from that used in the
earlier studies. The second was to investigatehow the species molecular replacement solution was refined with the R-factor search
of Ward et al. (1975) using the program RMINIM and subsequently
variation of thethrombin enzyme,bovine versus human, with rigid body least-squares using the program ROTLSQ (W. A.
affects the binding
of hirudin at themolecular level. The third Hendrickson, Columbia University) and 7.0 to 3.0 A data with IF1 2
was to determine the structure
of a bovine thrombin thatwas 100.
The structureof the hirudin component
was determined from 21F,,I
wholly in the a-form. All previously solved crystal forms of
bovine thrombin have contained significant amounts of pro- - IFcI electron density maps. The refinement of the complex was
teolytic derivatives (Martin et al., 1992). In this paper, we carried out using restrained least-squares procedures with the programsPROLSQandPROFFT
(Agarwal, 1978; Hendricksonand
report the determination of the crystal structureof the com- Konnert, 1979; Finzel, 1987) and by simulated annealing with the
plex betweenbovine a-thrombin and recombinant hirudin
program XPLOR (Brunger, 1988). The slow cool annealing protocol
variant 1 and a comparison of this structure with those
of the was used with XPLOR. The dynamics temperature started out
at
humana-thrombin-hirudin complexes(Rydel et al., 1990, 4000 K and decreased in intervals of 25 K to a final temperature of 0
1991; Grutteret
al., 1990) andthe bovine a-thrombin- K with 25 steps (0.5 fs/step) of Verlet dynamics a t each temperature.
The PROLSQ refinementwas carried outusing data 7.0 to 3.0 A with
FPA7-162complex (Martin etal., 1992) reported earlier.
IF1 > 2u. All the available data beyond 7.0 A were used for the
MATERIALS ANDMETHODS

Preparation of Proteins-Thrombin was prepared as previously
described (Martinet al.,1983) andhadapproximately
2000 NIH
clotting unitsper mg of protein. Itwas stored a t -20 "C in ammonium
phosphate before being set up for crystallization. Recombinant hirudin was purifiedfrom Escherichia coli cells transformed with the
pBR-CRM-CTAP-Hir plasmid (GenBank M88535), which codes for
hirudin fused to a CTAP leader sequence (Waleh et al., 1992). After
the leader sequence had been removed with cyanogen bromide, the
hirudin molecule was purified by high performance liquid chromatography on reverse phase columns (Winant et al.,1991). The recombinant protein, which lacks thesulfate group onTyr-63hthat
is
responsible for a 3-10-fold increase in the affinity of leech hirudin
for thrombin, had the same affinitydesulfated
as
hirudin from natural
sources (Stone andHofsteenge, 1986; Winant et al., 1991).
Crystallization-The complex was prepared by mixing bovine athrombin and recombinant hirudin
a t a molar ratio1:1.5. The crystals
were grown by the hanging drop method at
22 "C from reservoirs
containing 29% PEG 4000,250mM sodium phosphate buffer, pH 4.7,
94 mM NaC1, and 0.005% NaN?. The initial thrombin-hirudin concentration in the drop was 7 mg/ml. Polyacrylamide gel electrophoresis (Laemmli, 1970) on a crystal dissolved in 1%sodium dodecyl
sulfate solution (Martin et al., 1992) showed that no conversion of
6 , or y proteolytic derivatives had occurred
the a-thrombin to the@,
duringthe crystallization. This conversion has occurred a t least
partially in all other crystals of bovine a-thrombin with substrate
analogs or inhibitors that
we have grown inourlaboratory.The
crystalsoare orthorhombic, cell constants a = 59.11, b = 102.62, c =
143.26 A, space group C222] with 1 molecule per asymmetric unit.
The crystals of the human thrombin-hirudin complexes are tetragonal, P43212(Rydel et al., 1990; Grutter et al., 1990).
Data Collection-Intensity data were measured a t 22 "C on thetwo
largestcrystals(approximate dimensions
0.40 X 0.20 X 0.05 mm)
using a Siemens area detector witha Rigaku RU200H rotating anode
x-ray source and Supper graphite monochromator operated a t 40 kV
and 70 mA. The radiation used was CuKa. Two "sweeps" were made
for the first crystal, onefor the second. Each covered 110" in w with
440 frames of data. In the first crystal, the 6 angle was incremented
by 70" between sweeps. Each frame was measured for 5 min to ensure
that it contained at least1 million total counts. 19008 measurements
with I > u were merged, scaled, and averaged with the XENGEN

XPLOR and PROFFT refinements.
Structure Analysis-Hydrogen bonds were calculated in QUANTA
(Polygfn Corporation, Waltham, MA)
using as criteria a distance
of 3.5 A or less between the donor and acceptor atoms and
a value of
90" or more for the angles centered a t these atoms. A hydrophobic
contact was assumed to exist between 2 apolar residues if they had a
carbon-carbon distance of 4.0 A or less.
RESULTSANDDISCUSSION

Structure Solution-The orientation and position of the
thrombin component in the crystal was strongly indicated by
the molecular replacement searches. It corresponded to the
top peak in all searches with a high signal to noise ratio. The
(a, (3,y ) = (97.50",55.00",
top peak in the rotational search at
230.00")was 1.7 times larger than the nexthighest peak. The
top peak in each translation function, corresponding to the
position of thrombin in the unitcell at (x,y, z ) = (0.22, 0.22,
0.15),was 2.5 to 2.7 times larger than the next highest peak.
The R value after ROTLSQ was 0.357.
Initialrefinement
of thethrombincomponent
using
PROLSQ brought thecrystallographic R-factor to0.282. Residues lh-31h and 37h-42h of hirudin were then fit into the
electron density of a 21F01 - IFcI Fourier map. The NMR
model of hirudin (Folkers et al., 1989; Protein Data Bank
entry 5HIR) facilitated the fitting
processfor the aminoterminal domain. Nine alternate cycles of PROLSQ refinement followed by graphics intervention allowed us to build
the restof the hirudinmolecule and refit parts of the thrombin
component. The complex was further refined with XPLOR
to R = 0.171. The final refinement
of the structurewas carried
out with PROFFT. Toward the end of the PROFFT refinement, water molecules were included at 129 peaks that were
~ the lFul - IFcI Fourier map, greater than
greater than 2 . 9 in
0.70 in the 2 lFol - lFel Fourier map, and within hydrogen
bonding distances from appropriate atoms. The R value a t
the conclusion of the refinement was 0.161 (Tables I and 11).
The fit of parts of the final model to the electron density is
The abbreviationsused are: FPA7-16,residues 7-16 of fibrinopep- illustrated in Fig. 1.
Except for a few residues, both thrombin and hirudin are
tide A from the Aa-chain of human fibrinogen; CTAP, connective
at thel o
tissueactivatingprotein
111; PPACK, D-phenyl-L-prolyl-L-arginyl well defined in the electron density maps contoured
chloromethyl ketone.
level. There is no density for the first 13 residues at the NH,
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TABLEI
Refinement statistics from PROFFT

45h 0 (Fig. 2), the two hydrogen bonds from Lys-47h NZ to
Thr-4h OG1 and Asp-5h 0 (Table 111), and the hydrophobic
contact between Pro-46h andLeu-13h. Gln-49h through ProTotal number of atoms
2996
Number of solvent atoms
129
60hoform twoextended stretchesof chain, each approximately
Number of observations (7-2.5 A)
6958
15 A long, with a bend at Gly-54h. A type IV reverse turn for
Root mean square deviations
Glu-6lh
through Leu-64h (Table IV) gave the best fit for the
Bond distances
0.020 $
'
existing density.
Angle distances
0.042 4
In solution, only residues 2h through 30h and 37h through
1-4 distances
0.040 4
360 peptide planes
0.011 A
48h of hirudin are ordered (Folkers et al., 1989; Haruyama
40 aromatic planes
0.006 8,
and Wuthrich, 1989). A superposition of the C, atoms of the
Chiral volumes
0.15lOA3
structuredetermined by NMR(Folkers et al., 1989)with
Single torsion contacts
0.22 4
residues 5h-30h and 37h-48h of hirudin in the crystal
complex
Multiple torsion contacts
0.33 4
using
the
program
ALIGN
(G.
Cohen,
NIH;
SFtow
et al.,
Possible ( X . ..Y) H-bonds
0.36 A
1986) gave a root mean square difference of 0.83 A. When all
Planar torsion angles
2.8"
Staggered torsion angles
24.1"
atoms were included inthfsuperposition,the
rootmean
Orthonormal torsion angles
29.8"
square difference was 1.39A. These figures are comparable
with the deviationsfrom the average NMR structure (Folkers
et
al., 1989), suggestingthat theoverall structure of the NH,TABLEI1
terminal domain of hirudin changes little upon association
Final R-factors from PROFFT
as a function of resolution
with thrombin and subsequent crystallization(Fig. 3). A few
Reflections
Elohere
R.hd
large changes of 5 8, or more relative to the NMR structure
A
occur in the side chains of Asp-5h, which forms salt bridges
6.0"
398
0.198
0.198
with Arg-221A; Asn-l2h, which is located in the interior of
5.0
805
0.169
0.178
hirudin; Lys-27h, which is on thesurface of the complex; and
4.0
1659
0.135
0.151
Thr-41h andGlu-43h, whichinteract with a symmetry-related
3.5
1470
0.150
0.150
hirudin molecule. Gly-42h,which alsohasintermolecular
3.0
1864
0.174
0.156
contacts, exhibits no large differences from the NMR struc2.8
409
0.225
0.158
2.5
353
0.270
0.161
ture. Residues 31h through 36h, which were disordered in the
NMR studies, arewell-defined in our crystal structuredue to
Reflections beyond 7.0 A are not included.
the only other intermolecular contacts involving hirudin residues present in the structure, namely the close contacts of
terminus of the A-chain nor forseveral atoms in the side residues 34h, 35h,36h, and 38h with thrombin residues bechains Of G1u-14L and Arg-15 at the
terminus Of thelonging
to a symmetry-related complex. Residues49h-65h,
A-chain. In the B-chain of thrombin, the density for Thr-147 which also had no fixed structure in the NMR experiments,

through
Of the
loop is fragmented' and
there is nodensity for the side chain of Leu-245 atthe COOH
terminus. In hirudin, there is fragmented density forGln-49h
and Ser-50h,weak, but continuous densityfor the main chain
of His-5lh, Asn-52h, Glu-Glh, and Glu-62h, no density for
the CB atoms of Glu-6lh and Glu-62h, and little density
for
Gln-65h.
Structure of Hirudin-The secondary and tertiary structural features that we observe for hirudin are generally in
agreementwiththe
published descriptions of the complexes
with human thrombin (Rydel et al., 1990, 1991; Griitter et al.,
1990). In the complex with bovine a-thrombin, hirudin variant 1, whose sequence is shown in ~ i2,has
~ a.
NH,terminal domain, comprised of residues lh through 48h, and
an extended COOH-terminal polypeptide chain, comprised of
residues 49h through 65h (Figs. 3 and 4). The compactness of
the ~
~
~domain- is largely
~ due~to the ~three disulfide
~
i
bridges formed between Cys-6h and cys-14h, cys-16h and
domain is
Cys-28h, and cys-22h and cys-39h ( ~ i3).
~ This
.
also stabilized by 24 intramolecular hydrogen bonds of which
1 3 involve only main chain atoms (Fig. 2) and the remaining
11 involve side chain atoms (Table 111). Finally, there are
close contacts between the side chains of the hydrophobic
residues Leu-13h and Pro-46h, Val-21h and Tyr-3h, Ile-29h
and Val-40h, Leu-30h and Cys-Gh. The abilityof reduced and
denatured hirudin torefold at extremely high concentrations
and in the presence of a high concentration of guanidine
hydrochloride (Johnson et al., 1991) may resultfromthe
highly compact nature of the hirudincore and its stabilization
by numerous intramolecular contacts. Table IV summarizes
the secondary structuralelements of hirudin.The COOH
terminus of the hirudin core folds back to the NH, terminus
with the main chainhydrogen bond from Asn-12h N to Thr-

are generally well-defined in
our
crystal
structure
as the
result
of
interactions with thrombin (see below).
Structure of Bovine Thrombin"The model of bovine athrombin in this structureincludes residues 1 H through 247.
It is closely similar with the structures of molecules 2 and 3
of bovine a-thrombin in thecomplex with FPA7-16(Martin et
al., 1992). When these2 thrombin molecules are superimposed
onto the thrombinmolecule in the hirudin complex with the
the rms diJference between corresponding
program
C, atoms is 0.55 A and 0.56 A, respectively.
Residues 60A through 60D (the yppw loop) OCCUPY
positions in the hirudin and FPA7-16 complexes of bovine athrombin. The movement of this loop in the fibrinopeptide
complex relative to its position in human PPACK-thrombin
has been attributed to the presence of the fibrinopeptide in
l
the~active ~
site (Martin
et al., 1992). In this connection, itmay
be noted that Val-lh and Leu-13h Of hirudin OCCUPY similar
positions with Val-15f and Leu-Sf of the fibrinopeptide (Fig.
5) interacting, aswill be discussed later, with theresidues O f
the yppw loop (Fig. 6).
Twentythrombin residues are identified by ALIGN as
havingsignificantly different c, positionsinthehirudin
complex as opposed to the FPA7-16 complex of bovine athrombin.These residuesinclude thosethatarenot
well
defined either in the present structure
or in the fibrinopeptide
structure, or in both, such as Thr-147 through Ala-149D of
the autolysisloop, the terminiof the A-chain, and theCOOH
terminus of theB-chain. Glu-149E of theautolysis loop
interacts with a symmetry-related molecule in crystals of the
hirudin complex and is displaced by 2.5 and 2.4 A relative to
molecules 2 and 3, respectively, of FPA7-16tbrombin. Also,
small displacements ranging from 1.3 to 1.9 A are observed
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FIG. 1. Stereo views of the 21F,I
IFcI electron density map for residues l h through 3h of hirudin, contoured at 1.40 (a),
and residues 57h of hirudin and 75 of thrombin, contoured at 1.20( b ) .The salt bridge Arg-75 NE. . .Glu-57h OEl is illustrated in b.
Any unaccounted density in thesefigures corresponds toresidues that have been omitted for clarity.

for Gly-186A and Ser-36A through Gln-38. These residues are is 1318 2 (Martin et al., 1992).
The NH2-terminal 3 residues of hirudin, Val-lh, Val-2h,
on thesurface of thrombin but do not interact with symmetryrelated molecules, although Gln-38 interacts with Phe-56h in and Tyr-3h, bind in the active site to Ser-214 through Gly219 (Fig. 6) asa parallel (3-structure that contains4 hydrogen
its own complex (Fig. 7).
Interactions between Hirudin and Thrombin-The
earlier bonds, namely Val-lh N-Ser-214 0 (2.79 A), Gly-216 N+
crystallographic studies (Rydel et al., 1990, 1991; Grutter et Val-lh 0 (2.75 A), TyrD3hN-Gly-216 0 (2.69 A), and Gly219 N-Tyr-3h 0 (3.04 A). As noted inprevious studies (Rydel
al., 1990) showed that the mode of binding of hirudin to
thrombin is unique among other inhibitors
of serine proteases. et al., 1990,1991; Grutteret al., 1990), this interactionis quite
complexes (Huber
Most inhibitors interact with their targetenzymes, mainly in novel in that other serine protease inhibitor
and Bode, 1978; Read and James,1986; Bode et al., 1989) and
the region of the active site. In contrast, hirudin interacts
thefibrinopeptide complex (Martin et al., 1992)have an
with thrombin over an extended area, both within and far
antiparallel p structure. The side chains of Val-lh and Tyrfrom theactive site. Of the 65 residues of hirudin, 27 actually
3h project into the “apolar binding site” (Berliner and Shen,
contact thrombin. The total solvent-accessible surface area 1977; Bing et al., 1981; Sonder and Fenton, 1984) where Valburied in the interaction between thrombin and hirudin is
l h makes close contacts withTrp-GOD and Tyr-GOA, and Tyr3775 or 2.6 times the surface area buried in the interaction 3h makes close contacts with Trp-215. The hydrophobic nabetween trypsin and the 14residues of bovinepancrea$ic
ture of the region about Trp-215 explains the increase in K,
trypsininhibitorthatactuallycontacttrypsin
(1452 A’; that accompanies the hydroxyl-group ionization of Tyr-3h
Ruehlmann et al., 1973; Janin and Chothia, 1976; Huber and upon nitration (Winant et al., 1991) and the decrease in K,
Bode, 1978).The solvent-accessible surface area buried in the upon substitutionof Tyr-3h with phenylalanine
or tryptophan
interaction between thrombin and the10 residues of FPA7-16 (Lazar et al., 1991).
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The interactionsof the NH2-terminal tripeptideof hirudin main of hirudin with thrombin involve three salt bridges,
with thrombin are similar in the present structure and
in three hydrogen bonds, and two hydrophobic p a k The salt
human thrombin-hirudin (Rydel et al., 1990, 1991; Griitter et bridges are Arg-173 NH1.. .Glu-l7h OE2 (3.52 A), Arg-221A
al., 1990). However, in thehuman complexes, theaminoNH1.. .Asp-5h OD1 (2.93 A), and Arg-221A NH2.. .Asp-5h
terminal group of hirudin formstwo hydrogenbonds to throm- OD1 (3.08A). Tbe three hydrogen bonds are Lys-22t NZ+
bin. One hydrogen bond is to thecarbonyl oxygen of Ser-214, Ser-19h 0 (3.33 A), Lys-224 NZ-Asn-2Oh OD1 (3.38 A), and
as in the present structure. The
second is to the catalytic Ser- Val-2lh N-Glu-217 OE2 (3.11
The two hydrophobic
195 in the structure done at pH
4.5 (Rydel et al., 1991) and to interactions involve Leu-13h with Pro-6OC and Val-2lh with
thecatalytic His-57 inthestructure
done atneutralpH
Ile-174 (Fig. 6).
(Griitter et al., 1990). The latterhydrogen bond is notpossible
In contrast to the present structure,
Asp-5h and Arg-221A
in the bovine thrombin-hirudin crystalswhich were grown at in human thrombin-hirudin (Rydelet al., 1991) interact with
p H 4.7. At this pH, His-57 is most
likely protonated and
only one salt bridge contact and Lys-224 NZ is hydrogen
cannot function as a hydrogen bond acceptor. However, we bonded only to Ser-19h OG. Since these residues are on the
also do not observe a hydrogenbond to Ser-195 in the presentsurface of the complex and do not interact with symmetrystructure. This observation suggests that a second hydrogen
related molecules, it is possible that there is some flexibility
bond for the amino-terminal group is not essential for the in the binding of residues 4h through 48h of the hirudin core
binding of hirudin to thrombin.
to thrombin.
Beyond Tyr-3h, the interactions of the NH2-terminal doModifications within the first 5 amino-terminal residues of
hirudin can reduce the affinity with thrombin
by 2 to 6 orders
of magnitude (Lazar et al., 1991). These changes affect direct
P-48h
interactions between hirudin and the
active site and the
apolar
Q-49h
bindingsite of thrombin. However, the large reductionin
I
I
K-47h
S-50h
affinity suggests that these changes also disrupt other stabiI
I
lizing interactions (Lazar et al., 1991), such as the salt link
P-46h
between
Asp-5h and Arg-221A and the two hydrogen bonds
I
from Lys-47h to Thr-4h andAsp-5h in the present structure
N-52h
(Table 111).
I
D-53h
It is interesting that the NH2-terminaldomain of hirudin
I
interacts
withmost of the residues which definethe 9 subsites
C-54h
that bind fibrinogen to thrombin. Thus, Trp-GOD that conI
D-55h
tacts Val-lh is partof S2, Gly-216 that interacts asa parallel
(I-strand with Val-lh and Tyr-3h corresponds to S3,
Arg-173
I
F-56h
that makesa salt bridge with Glu-17h corresponds to S6, ProI
60C that interacts with Leu-13h is part of S8 but was inadE-57h
vertently omitted by Martin et al. (1992), Tyr-GOA that also
I
contacts Val-lh is part of S8 and S9, and Ile-174 and TrpE-58h
215,
which interact with Val-2lh and Tyr-3h, respectively,
I
Y-3h
C-16-N-20h
I-i9h e Q - 3 8 h
are part of S9. The S1 subsite, which is defined by the 6
I
I
I
I
I
thrombin residues that interact with Arg-16f, is the major
E-17h
S-19h
L-30h
N-37h
P-60h
Q-65h
exceptionin that onlySer-214also interacts with hirudin.
I
I
I
I
Subsites S4, S5, and S7 do not exist in that no thrombin
G-18h
G-31h
K-36h
E-61ht"L-64h
residues interact with the corresponding
residues in FPA7-1fi.
I
I
I
S-32h-E-35h
Martin et al. (1992) discuss the interactions of fibrinogen
I
I
with the apolar binding siteof thrombin in termsof a hydroE - u - 6 3 h
phobic cage about Phe-8f thatis formed by thrombin residues
Tyr-GOA,Pro-GOC,Trp-GOD,
Leu-99, Ile-174, andTrp-215
FIG. 2. Amino acidsequence and main chain hydrogen and fibrinogen residues Leu-Sf, Gly 13f, and Val-15f. When
the structures of the hirudin and FPA7-1ficomplexes with
bonds of hirudin. Arcs represent reverse turns.

A).

7rh

ITh

FIG. 3. A stereo view of the C a
structure of the NHz-terminal domain of hirudin in the crystal(thick
lines) and in solution (thin lines).
The three disulfide bridges of this domain arealso shown. The solution structure has been superimposed on the crystal structure on the basis of the C a coordinates of residues 5h through30h and
37h
through
48h with the program
ALIGN.
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FIG. 4. A stereo view of the C a
structure of the hirudin-thrombin
complex. Thick lines represent hirudin,
thin lines represent thrombin.

TABLE
I11
Hydrogen bonds involving side chain atoms in the NH2-terminal
domain of hirudin

the same position as
Gly-12f of the fibrinopeptide (Fig. 5) but
has a bulky side chain that can interact with
Ile-174.
The COOH-terminal peptide of hirudin binds on the surface
Acceptor
Donor
of thrombin (Fig. 4) between the two loops formed by Phe-34
A
through Leu-41 and Lys-70 through Glu-80. This region is
rich inpositively charged sidechains and hasbeen considered
Thr-7h N
OEl
Gln-llh
3.06
OG1
Thr-7h
3.20
Gl n - l l h NE2
in the earliercrystallographic studies (Rydelet al., 1990,1991;
Gly-23h 0
3.21
Asp-12h ND2
Griitter et al., 1990) to be the secondary bindingsite for
Asn-26h 0
2.87
A~p-12hND2
fibrinogen.
In the first segment of extended chain, Asn-52h
Glu-17h 0
3.14
Asn-20h ND2
OD1 forms a hydrogen bond with Asn-143 ND2 (3.34 A) apd
OD1
Asp-12h
3.15
Gln-24h NE2
Asp-53h OD2 forms a salt bridge with Arg-73 NH2 (2.61 A).
Thr-41h 0
3.03
Lys-27h NZ
Gly-31h N
Asn-37h OD1
3.40
In the second segment, Asp-55h makes two salt bridge conGlu-17h OEl
3.47
Cys-39h N
tacts with Arg-73, namely Arg-73 NH2. . .Asp-55h OD2 (4.93
Thr-4h OG1
3.09
Lys-47h NZ
A) and Arg-73 NH1. . .Asp-55h OD1 (4.94 A). The N atom-of
Lvs-47h NZ
Asp-Sh 0
2.62
Phe-56h makes a hydrogen bond with Gln-38 OEl (3.12 A).
Its phenyl side chain is sandwiched between the ring of Phe34 and the CB-CG2 bond of Thr-74, making close contacts
TABLE
IV
with Phe-34 and Leu-40. The stacking of the two phenylalaSecondary structural elementsof hirudin
nine rings has the characteristicedge-on pattern (Burley and
structure
Secondarv Residues
Petsko, 1985).Glu-57h is engaged ip two hydrogen bond
Parallel p
Thr-4h through Cys-6h; Cys-14h
contacts, Glu-57b N+Thr-74 0 (3.74 A) and Tyr-76N+Gluthrough Cys-16h
57h O E l (3.78 A), and a salt bridge, Arg-75 NE.. .Glu-57h
Anti-parallel p ladderb
Cys-l4h through Cys-16h; Asn-2Oh
through Cys-22h
O E l (3.46 A) (Fig. 1). Leu-65,Ile-82, andTyr-76 forma
Anti-parallel p ladder
Asn-26h through Leu-30h; Asn-37h
hydrophobic cavity on the surface of thrombin that accomthrough Thr-41h
modates the side chains of the hydrophobic residues at the
Thr-45h through Pro-48h
Polyproline I1 helix
COOH terminus of hirudin -Ile-59h, Pro-6Oh, Tyr-63h, and
11
reverse
turn'.d
Glu-8h through Gl n - l l h
Leu-64h. Ile-59hcontacts Tyr-76 and
Ile-82, Pro-6Oh contacts
Glu-l7h through Asn-2Oh
11' reverse turn'*d
11 reverse turn'.d
Gly-23h through Asn-26h
Tyr-76, and Tyr-63h contacts Leu-65 and Ile-82, as well as
I1 reverse turn'.'
Ser-32h through Glu-35h
Ile-59h and Pro-6Oh.
IV reverse turn'se
Glu-6lh through Leu-64h
The fact that the
hydroxyl group of Tyr-63h is not involved
" Th e Cys-6h N-Leu-15h-0 hydrogen
bond of 3.63 A is slightly
in any stabilizing interactions with thrombin
explains the
longer than our cutoff of 3.5 A but it hasbeen included as part of the insignificant difference in binding energy when Tyr-63h in
ladder.
Thr-4h through Cys-6h, Cys-14h through Cys-16h, and Asn-2Oh recombinant hirudin is replaced by phenylalanine (Betzet al.,
1991). Iodination or nitration of Tyr-63h reduces the pK of
through Cys-22h form a n approximate, mixed 0 pleated sheet.
the hydroxyl group and increases the affinity of hirudin for
' Chou and Fasman, 1977.
Reverse turn without a hydrogen bond.
human thrombin by 3-10-fold, as reported by Winant et al.
Reverse turn with a hydrogen bond.
(1991), who suggested that the negatively charged hydroxyl
group on the modified tyrosine ring effectively mimics the
thrombin are superimposedwith ALIGN (Fig. 5 ) , Leu-13h acidic sulfatotyrosine residue in leech hirudin. In the present
and Val-lhoccupy the same positionsrelative to thrombin as structure, thehydroxyl group of Tyr-63h is located 4.95 A and
Leu-Sf and Val-15f of the fibrinopeptide. Further, Tyr-3h is 4.72 A, respectively, from the hydroxyl group of Tyr-76 and
close to Phe-8f and intersects the peptide bond
between Gly- the amide nitrogen of Ile-82 that make hydrogen bonds with
13f and Gly-14f. Leu-13h and Val-lhreplace Leu-Sf and Val- sulfate oxygens on Tyr-63h in the
complex of sulfated hirugen
15f in the cluster, and Tyr-3h replaces Phe-8f and Gly-13f. with human a-thrombin (Skrzypczak-Jankun
et al., 1991).
The hydrophobic cluster in the hirudin structure contains an Single bond rotations cannot bring these groups within hyadditional residue, Val-2lh (Fig. 6), which occupies essentially drogen bonding distance without creating steric
conflicts with
"
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FIG. 5. A stereo view of the residues of hirudin (thick lines)that are
near residues of fibrinopeptide A
(thin lines)bound to thrombin.
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FIG. 6. A stereo view of the interactions of the NHz-terminal tripeptide of hirudin with thrombin. Residues 13h and 21h of
hirudin that interact with the apolar binding site of thrombin are also shown. Thick lines represent hirudin, thin lines represent thrombin,
and dashed lines represent hydrogen bonds.

nearby atoms. However, in the present structure, the amino 55h are approximately2 A closer to theguanidinium group of
group of Lys-81 can be brought within3.0 A from thehydroxyl Arg-73 in the human structure. Second, the hydrogen bond
group of Tyr-63h by single bond rotations, and it ispossible Phe-56h N-Gln-38 OEl is not present in the complex with
that these two groups forma favorable ion pair in the nitratedthe human enzyme. Third, Glu-57h forms a salt bridge with
or iodinated structure.This proposal is supported by an Arg-75' of a symmetry-related complex in human thrombinalternative interpretation of the electron density of the sul- hirudin crystals, althoughGlu-57h is also close to the Arg-75
fated hirugen structure (Skrzypczak-Jankun et al., 1991) that residue in its own complex and a salt bridge was predicted to
occur in solution. In the present crystal structure,
Glu-57h is
places the side chain of Lys-81 in the density attributed to
two waters involved in a hydrogen bonding network with the not near any symmetry-relatedmolecules and forms the predicted intramolecular salt bridge with Arg-75. Fourth, Gluthird sulfate oxygen.
with Arg-77A in human thrombinThere are several differences in the polar interactions of 58h forms an ion pair
hirudin whereas it does not interact with any thrombinresithe COOH-terminal polypeptide of hirudin with thrombin
between the present structure and thatof human thrombin- due in the present structure. With the exception of Glu-57h
hirudin (Rydel et al., 1991). First, thecarboxyl atoms of Asp- in human thrombin-hirudin, these
residues are on thesurface
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75
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.43
FIG. 7. A stereo view of the interactionsof residues 52h through 58h of hirudin with thrombin.Thick lines represent hirudin,

t h i n lines represent thrombin, and dashed lines represent hydrogen bonds.

Lys-149E is replaced by an acidic glutamatethatcannot
of the complex and do not interact with symmetry-related
interact withAsp-55h. This is theonly difference betweenthe
molecules.
two crystal structures thatwe can with certainty attribute to
Hirudin bindsmore tightly to human as comparedbovine
to
species variation of the thrombin enzyme.
thrombin (Dodt et al., 1988, 1990).
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